Novo Nordisk
US Markets

UK Regulators Reprimand Novo Nordisk (NYSE: NVO) for Non-Disclosure of Healthcare Sector Payments

/

COPENHAGEN – UK regulators reprimanded Danish drugmaker Novo Nordisk (NYSE: NVO) for failing to disclose fees and expenses paid to […]

UK Regulators Reprimand Novo Nordisk (NYSE: NVO) for Non-Disclosure of Healthcare Sector Payments Read More »